Clinical Pharmacogenetics Implementation Consortium

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update. | National Guideline Clearinghouse

Clinical Pharmacogenetics Implementation Consortium

• Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update. This updates a previously published guideline summary.

• GUIDELINE SUMMARY
 
• NGC:011376
 
• 2018 FEB
 
•  NEATS Assessment
   LEARN MORE ABOUT NEATS ASSESSMENT

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.